JAGX Jaguar Health Inc
82,266
$0.2674
$0.0306
(10.27%)
| Watchers | 82,266 |
| 52-Wk Low | $0.0512 |
| 52-Wk High | $1.22 |
| Market Cap | $76.8M |
| Volume | 19.95M |
| 52-Wk High | $1.22 |
| 52-Wk Low | $0.0512 |
12 titoli sanitari in movimento, pre-market del 10/04/2024Benzinga • 29 days ago
Titoli in rialzo
Il titolo Evoke Pharma (NASDAQ:EVOK) ha osservato un incremento del 41,47% a 0,75 dollari durante la sessione pre-market di mercoled .
Le azioni di Jaguar Health (NASDAQ:JAGX) sono...
Share to Feed
Acciones al alza
Jaguar Health (NASDAQ:JAGX) avanzaron un 43,99% para establecerse en los 0,13 d lares durante la sesi n del pre-market del mi rcoles.
Adial Pharmaceuticals (NASDAQ:ADIL) ganaron un...
Jaguar Health reported all proposals were approved by stockholders, and the company will not be implementing a reverse split at this time.
read more...
Dr. Massimo Radaelli's core focus will be on further expanding Jaguar's commercial footprint outside the U.S.Dr. Radaelli was instrumental in facilitating the recent out-license agreement with GEN...
Related Stocks: NAS:JAGX...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
Net revenue was approximately $9.8 million for the year ended December 31, 2023 versus approximately $12.0 million for the year ended December 31, 2022, a decrease of 18%Net Q4 2023 revenue of...
Jaguar Health, Inc. (JAGX) Q4 2023 Earnings Call Transcript...
Jaguar Health, Inc. ( NASDAQ:JAGX ) shareholders are no doubt pleased to see that the share price has bounced 55% in...
Click here to register for April 1 investor webcastCompany plans to file its Earnings Report on April 1, 2024 on Form 10-K for the year ended December 31, 2023SAN FRANCISCO, CA / ACCESSWIRE / March...